NCT04188665View on ClinicalTrials.gov

Using MASL to Combat Oral Cancer

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 29, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
DRUG

MASL

Patients treated with MASL lozenge

OTHER

Placebo

Patients treated with placebo lozenge

Trial Locations (4)

07103

New Jersey Medical School, Newark

Rutgers School for Dental Medicine, Newark

University Hospital, Newark

08084

Rowan University, Stratford

All Listed Sponsors
collaborator

Rutgers University

OTHER

lead

Rowan University

OTHER